DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here: https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule



More Latest News

Urgent National Drug Shortage
October 16, 2017

Please Click for Details on the Urgent National Drug Shortage: Lidocaine with Epinephrine and Bupivacaine with Epinephrine Continue reading


Florida Department of Health, Fingerprint Retention
September 27, 2017

Florida statute requires individuals who were fingerprinted on or after Jan. 1, 2013 to have their background results retained in Florida’s Care Provider Background Screening Clearinghouse. Continue reading